1)Osteoprotegerin护骨素
1.Regional differences of the single T149-C mutation polymorphism in the promoter region of osteoprotegerin gene;护骨素基因启动子区T149-C基因型和等位基因频率分布的区域性差异
2.Ipriflavone up-regulates mRNA expression of osteoprotegerin in lumbar vertebra of ovariectomized rats;异普黄酮抗卵巢切除大鼠的骨质疏松与上调腰椎护骨素mRNA的表达
3.Effect of raloxifene and estradiol on the biological function and osteoprotegerin expression of osteoblasts in vitro;雌二醇与雷洛昔芬对体外培养成骨细胞生物学功能的影响及护骨素表达的调控
英文短句/例句
1.The Association Study Amongst Bone Mineral Density, Bone Turnover Markers, and Osteoprotegerin Gene Polymorphism in Females;女性骨密度、骨转换生化指标及护骨素基因多态性的相关性研究
2.The Effects of TNF-α on the Expression of OPG in Mouse Marrow Stromal MBA-1 and in Human Osteoblast-like Cells;TNF-α对人成骨样细胞和鼠骨髓基质细胞护骨素表达的作用
3.Effect of OPG on the Stromal-like Tumor Cells of the Giant Cell Tumor in Vitro;护骨素对人骨巨细胞瘤体外单核基质细胞培养影响的研究
4.Effects of pioglitazone on the osteoprotegrin and bone mineral density in patients with type 2 diabetes mellitus吡格列酮对2型糖尿病患者护骨素和骨密度的影响
5.Effects of Glucose on the Expressions of OPG and TRAIL in MG63 Cells;葡萄糖对MG63细胞护骨素及TRAIL表达的影响
6.Experimental Study on Prevention and Cure Glucocorticoid-Induced Avascular Necrosis of Femoral Head by the Hugu-Electuary;护骨冲剂防治激素性股骨头坏死的实验研究
7.Experimental Study of the Osteoprotegerin and the Ovariectomized Rat Model of Osteoporosis;骨保护素与去卵巢大鼠骨质疏松模型实验研究
8.Relationship between Serum Osteoprotegerin Level and Osteoporosis of Type 2 Ddiabetes Patients2型糖尿病患者骨保护素与骨质疏松的关系
9.A Study on the Expression of Osteoprotegerin during the Replacement of Dog s Primary and Permanent Teeth;犬乳恒牙替换期骨保护素表达的研究
10.Effect of recombinant osteoprotegerin on glucocorticoid-induced osteoporosis in rats重组骨保护蛋白对糖皮质激素性骨质疏松的保护作用
11.Protection effects of calcitonin on articular cartilage and subchondral bone of rat knee joint with osteoarthritis降钙素对OA大鼠关节软骨及软骨下骨的保护作用
12.OSTEOPROTEGRIN AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND mRNAs EXPRESSION IN BMSCs OF GLUCOCORTICOID-INDUCED NECROSIS OF THE FEMORAL HEAD PATIENTS激素性股骨头坏死BMSCs骨保护素/NF-κB受体活化因子配基mRNA的表达
13.A balanced bone support formula including calcium for strengthening bones.均衡的骨骼维护配方,包括强化骨骼的钙质营养素。
14.Inhibitory Effect of Plasmid Delivery of Osteoprotegerin on Alveolar Bone Resorption Resulting from Experimental Periodontitis in Rats;人骨保护素质粒转染抑制大鼠实验性牙周炎骨吸收的研究
15.Study of ex vivo OPG Gene Therapy in Preventing Wear Debris Induced Osteolysis;人骨保护素基因治疗抑制磨损颗粒诱导骨溶解的实验研究
16.The Efects of Recombinant Human Osteoprotegerin on the Osteoclasts Indueced by the Polyethylene Particles;重组人骨保护素对聚乙烯颗粒刺激破骨细胞功能的影响
17.The Culture and Identification of Rat MSC Cell Lines Modified by Osteoprotegerin Gene;骨保护素基因修饰的大鼠骨髓基质细胞系的培养、表达与鉴定
18.The Study of Relationship between Serum Osteoprotegerin Level and Renal Osteodystrophy in Maintenance Hemodialysis Patients;维持性血液透析患者血清骨保护素与肾性骨病关系的研究
相关短句/例句
OPG护骨素
1.Effects of Glucose on the Expressions of OPG and TRAIL in MG63 Cells;葡萄糖对MG63细胞护骨素及TRAIL表达的影响
2.Methods:The expression of osteoprotegerin(OPG),receptor activator of nuclear factor(NF)-kappaB ligand(RANKL),interleukin-6(IL-6) and estrogen receptor-alpha(ER-α) was detected by using RT-PCR and Western blot in hOB.方法:采用细胞培养结合RT-PCR、Westernblot技术观察金雀异黄素对护骨素(OPG)、破骨细胞分化因子(RANKL)、白介素-6(IL-6)等基因mRNA及蛋白质表达。
3.PURPOSE: To investigate the change of osteoprotegerin (OPG) and OPGL expression and its significance in condylar cartilage after anterior disc displacement (ADD).目的:探讨关节盘前移位后髁突软骨中护骨素(osteoprotegerin,OPG)及其配体(osteoprotegerinligand,OPGL)表达的变化及意义。
3)osteoprotegerin(OPG)护骨素
1.AIM:To study the effect of hypoxia on gene expression of receptor activator of NF-κB ligand(RANKL),osteoprotegerin(OPG) and tumor necrosis factor-α(TNF-α) in myeloid cells of rats.目的:探讨低氧对大鼠骨髓细胞核因子κB受体活化因子配体(RANKL)、护骨素(OPG)和肿瘤坏死因子-α(TNF-α)基因表达的影响。
4)osteoprotegerin(OPG)骨保护素
1.Objective:To study the expression of IL-10 at protein level in human dental follicle cells(HDFCs)and the effect of IL-10 on osteoprotegerin(OPG) secretion.目的:研究人牙囊细胞白细胞介素-10(IL-10)蛋白的表达及其对骨保护素(osteoprotegerin,OPG)表达的影响。
2.In addition,the Semiquantitative RT-PCR was using to assessed the regulation of dexamethasone(DEX)for Osteoprotegerin(OPG)or Ligand of receptor activator of nuclear factor kappa B(RANKL)in FRS.采用MTT掺入法检测细胞活率变化,分别筛选出诱导细胞增殖与凋亡的药物浓度;半定量PCR法检测不同浓度下地塞米松对骨保护素(Osteoprotegerin,OPG)和核因子κB受体激活剂受体配体(Ligand of receptor activator of nuclear factor kappa B,RANKL)基因在mRNA水平上的调控作用;流式细胞术检测细胞周期分布和凋亡率变化,显微镜观察FRSs存活、增殖和凋亡变化。
3.Objective To study the expression and significance of osteoprotegerin(OPG)in the development of dogs permanent teeth germs.目的:探讨犬乳恒牙替换过程中骨保护素在犬恒牙胚发育中的表达及意义。
5)osteoprotegerin骨保护素
1.Effect of advanced glycation end-products on the gene expression of osteoprotegerin in cultured rat vascular smooth muscle cells;糖基化终产物对大鼠血管平滑肌细胞骨保护素mRNA表达的影响
2.Effects of resveratrol on the expression of osteoprotegerin and receptor activator for NF-κB ligand in femurs of ovariectomized rats;白藜芦醇对去卵巢大鼠股骨骨保护素及核因子κB受体活化子配体表达的影响
3.The mechanism of osteoprotegerin on mineralization of enamel;骨保护素及其在釉质矿化中的作用机制
6)OPG骨保护素
1.Study of the PKA and PKC Signal Transduction Pathway of Regulation of OPG and RANKL mRNA Expression by hPTH(1-34);人甲状旁腺激素调节骨保护素及其配体基因表达的PKA、PKC信号传导通路研究
2.Effect of rhIGF-1 on the proliferation and differentiation and OPG,RANKL gene expression in rat osteoblast;rhIGF-1对成骨细胞增殖、分化及骨保护素、骨保护素配体基因mRNA表达的影响
3.Effects of cobalt and chromium ions on osteoblasts:cytotoxicity and the releasion of RANKL and OPG钴铬离子对成骨细胞细胞毒性及对其分泌骨保护素及其配体的影响
延伸阅读
紫杉醇 ,紫素,特素,紫烷素,路泰,泰素药物名称:红豆杉醇英文名:Taxol别名: 红豆杉醇;紫杉醇 ,紫素,特素,紫烷素,路泰,泰素 外文名:Taxol ,TAX,Paclitaxel,PTX适应症: 本品适用于一线或其后的卵巢转移性癌化疗失败以后的治疗。 用量用法: 稀释的泰素注射液应先经过所连接的直径不超过0.22μm孔膜的滤过装置,使用前先用地噻米松、苯海拉明及H2一受体拮抗剂。 注意事项: 1.可有白细胞、血小板减少、贫血(血色素减少)、感染、粘膜炎、出血、过敏反应、低血压、心动过缓、心电图异常、关节痛、肌肉痛、转氨酶和胆红素升高、脱发、恶心及呕吐。 2.对本品有过敏者及骨髓抑制患者忌用。 规格: 浓缩注射液:30mg/支。 类别:抗肿瘤植物成分药